10-K Decoder · All companies

Context Therapeutics Inc.

CNTX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$0K$0K
Operating income−$39.7M−$29.9M−32.7%
Net income−$36.1M−$26.7M−35.1%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 10, 2026

$Q3 2026Year earlierChange
Revenue$0K$0K
Operating income−$8.00M−$10.6M+24.5%
Net income−$7.60M−$9.70M+21.6%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Context Therapeutics's revenue in FY2025?
$0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Mar 2026.
Was Context Therapeutics profitable in FY2025?
No: net income was −$36.1M and operating income −$39.7M in FY2025.
What was Context Therapeutics's revenue in Q3 2026?
$0K (n/a vs a year earlier), per its Form 10-Q filed Nov 10, 2026.